Stories
Slash Boxes
Comments

SoylentNews is people

posted by LaminatorX on Tuesday January 13 2015, @04:32PM   Printer-friendly
from the ought-to-be-enough-for-anybody dept.

The Guardian has an interesting article on the current quest sweeping Silicon Valley to disrupt death and the $1m prize challenging scientists to “hack the code of life” and push human lifespan past its apparent maximum of about 120 years. Hedge Fund Manager Joon Yun's Palo Alto Longevity Prize, which 15 scientific teams have so far entered, will be awarded in the first instance for restoring vitality and extending lifespan in mice by 50%:

Billionaires and companies are bullish about what they can achieve. In September 2013 Google announced the creation of Calico, short for the California Life Company. Its mission is to reverse engineer the biology that controls lifespan and “devise interventions that enable people to lead longer and healthier lives”. Though much mystery surrounds the new biotech company, it seems to be looking in part to develop age-defying drugs. In April 2014 it recruited Cynthia Kenyon, a scientist acclaimed for work that included genetically engineering roundworms to live up to six times longer than normal, and who has spoken of dreaming of applying her discoveries to people. “Calico has the money to do almost anything it wants,” says Tom Johnson, an earlier pioneer of the field now at the University of Colorado who was the first to find a genetic effect on longevity in a worm.

Why might tech zillionaires choose to fund life extension research? Three reasons reckons Patrick McCray, a historian of modern technology at the University of California, Santa Barbara. First, if you had that much money wouldn’t you want to live longer to enjoy it? Then there is money to be made in them there hills. But last, and what he thinks is the heart of the matter, is ideology. If your business and social world is oriented around the premise of “disruptive technologies”, what could be more disruptive than slowing down or “defeating” ageing? “Coupled to this is the idea that if you have made your billions in an industrial sector that is based on precise careful control of 0s and 1s, why not imagine you could extend this to the control of atoms and molecules?,” he says.

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by ikanreed on Tuesday January 13 2015, @07:45PM

    by ikanreed (3164) Subscriber Badge on Tuesday January 13 2015, @07:45PM (#134505) Journal

    A claim you make on no particular basis.

    The big cost here is going to be research. Once they develop a technology to treat aging, it really likely will be moderately cheap(no more than prescription drugs) to mass produce.

    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2  
  • (Score: 1) by fritsd on Tuesday January 13 2015, @08:49PM

    by fritsd (4586) on Tuesday January 13 2015, @08:49PM (#134529) Journal

    I agree with you about the cost aspect.

    It's beside the point that it would be moderately cheap to mass produce. A billionaire would give his last billion for this cure, therefore the optimum price point is going to be 1 billion?

    Maybe they could get even more profit by dropping the price and selling it to more customers; but then it would seem less "exclusive" so the billionaires would think "meh.. screw it, I'll wait 20 years and then try if it has become even cheaper".

    And it doesn't even have to be real; think about what an expert like Bernie Madoff [wikipedia.org] could achieve with a project like this, immortality for the exclusive few .. if you keep your mouth shut.